首页|期刊导航|广东医学|合并T2DM的老年COPD患者IL-10/IL-17比值、IL-4/IL-13比值特征与急性加重风险的相关性

合并T2DM的老年COPD患者IL-10/IL-17比值、IL-4/IL-13比值特征与急性加重风险的相关性OA

Cytokine imbalance and exacerbation risk in COPD with T2DM:role of IL-10/IL-17 and IL-4/IL-13 rati-os

中文摘要英文摘要

目的 探讨合并2型糖尿病(T2DM)的老年慢性阻塞性肺疾病(COPD)患者白细胞介素(IL)-10/IL-17比值、IL-4/IL-13比值特征与急性加重风险的相关性.方法 本研究为前瞻性观察性研究,选取2022年4月至2024年4月期间就诊的212例合并T2DM的老年稳定期COPD患者作为研究对象,根据患者1年内COPD急性加重的次数分为频发组和非频发组.对比两组患者基础临床特征、血清IL水平的差异.通过Spearman相关性分析及多因素logistic回归分析筛选合并T2DM的老年COPD患者急性加重频繁的相关因素.通过受试者工作特征(ROC)曲线及曲线下面积(AUC)评估IL-10/IL-17比值、IL-4/IL-13比值独立及联合预测合并T2DM的老年COPD患者急性加重频繁的效能.结果 入组患者平均年龄(69.77±3.83)岁,其中频发组患者96例(45.3%)、非频发组患者116例(53.7%).频发组患者年龄、COPD病程、T2DM病程、慢性阻塞性肺疾病全球创议(GOLD)3~4级占比、血清IL-4、IL-13、IL-17、IL-4/IL-13比值均高于非频发组患者,血清IL-10、IL-10/IL-17比值均低于非频发组患者(P<0.05).Spearman相关性分析表明在所有合并T2DM的老年COPD患者、非频发组患者及频发组患者中,急性加重次数均与血清IL-4、IL-13、IL-17、IL-4/IL-13比值呈正相关性,与血清IL-10、IL-10/IL-17比值呈负相关性(P<0.05).多因素logistic 回归分析提示 IL-4(OR=1.058,95%CI:1.013~1.104)、IL-13(OR=1.052,95%CI:1.007~1.098)、IL-17(OR=1.081,95%CI:1.027~1.137)、IL-4/IL-13 比值(OR=5.758,95%CI:2.124~15.621)较高,IL-10(OR=0.909,95%CI:0.866~0.955)、IL-10/IL-17 比值(OR=0.281,95%CI:0.128~0.620)较低,均与合并T2DM的老年COPD患者急性加重频繁密切相关(P<0.05).ROC曲线分析表明IL-10/IL-17比值、IL-4/IL-13比值独立及联合预测合并T2DM的老年COPD患者急性加重频繁的AUC(95%CI)为 0.704(0.631~0.776)、0.707(0.635~0.780)、0.803(0.742~0.863).结论 合并 T2DM 的老年稳定期COPD患者IL-10/IL-17比值、IL-4/IL-13比值均与急性加重风险密切相关,两个比值均可作为评估合并T2DM的老年稳定期COPD患者急性加重风险的重要指标,为临床更准确识别高风险群体提供有力支持.

Objective To investigate the association between interleukin IL-10/IL-17 and IL-4/IL-13 rati-os and the risk of acute exacerbations in elderly patients with chronic obstructive pulmonary disease(COPD)complicated by type 2 diabetes mellitus(T2DM).Methods This prospective observational study included 212 elderly patients with stable COPD and comorbid T2DM treated between April 2022 and April 2024.Patients were categorized into a frequent ex-acerbation group and a non-frequent exacerbation group based on the number of COPD exacerbations within one year.Baseline clinical characteristics and serum cytokine levels were compared between groups.Spearman correlation analysis and multivariate logistic regression were used to identify factors associated with frequent exacerbations.Receiver operating characteristic(ROC)curve analysis was performed to evaluate the predictive value of IL-10/IL-17 and IL-4/IL-13 ratios,alone and in combination.Results The mean age of participants was(69.77±3.83)years.A total of 96 pa-tients(45.3%)were classified as frequent exacerbators and 116(54.7%)as non-frequent exacerbators.Compared with the non-frequent group,patients in the frequent exacerbation group had higher age,longer disease duration of COPD and T2DM,a higher proportion of GOLD stage Ⅲ-Ⅳ,and elevated serum levels of IL-4,IL-13,IL-17,and IL-4/IL-13 ratio,while IL-10 levels and IL-10/IL-17 ratio were significantly lower(P<0.05).Spearman analysis showed that the number of exacerbations was positively correlated with IL-4,IL-13,IL-17,and IL-4/IL-13 ratio,and negatively correlated with IL-10 and IL-10/IL-17 ratio(all P<0.05).Multivariate logistic regression identified higher IL-4(OR=1.058,95%CI:1.013-1.104),IL-13(OR=1.052,95%CI:1.007-1.098),IL-17(OR=1.081,95%CI:1.027-1.137),and IL-4/IL-13 ratio(OR=5.758,95%CI:2.124-15.621),as well as lower IL-10(OR=0.909,95%CI:0.866-0.955)and IL-10/IL-17 ratio(OR=0.281,95%CI:0.128-0.620),as independent factors associated with frequent exacerbations(P<0.05).ROC analysis showed that the AUC(95%CI)for IL-10/IL-17 ratio,IL-4/IL-13 ratio,and their combination were 0.704(0.631-0.776),0.707(0.635-0.780),and 0.803(0.742-0.863),respectively.Conclusion Both IL-10/IL-17 and IL-4/IL-13 ratios are significantly associated with the risk of acute exacerbations in elderly patients with COPD and T2DM.These ratios may serve as useful biomarkers for risk stratification and early identification of high-risk individuals in clinical practice.

库尔班·亚森;张海涛

新疆巴州人民医院呼吸与危重症医学科(新疆巴音郭楞蒙古自治州 841000)新疆巴州人民医院呼吸与危重症医学科(新疆巴音郭楞蒙古自治州 841000)

医药卫生

老年患者2型糖尿病慢性阻塞性肺疾病急性加重白细胞介素

elderly patientstype 2 diabetes mellitusacute exacerbation of chronic obstructive pulmonary dis-easeinterleukins

《广东医学》 2026 (4)

516-522,7

自治区卫生健康青年医学科技人才专项科研项目(WJWY-202257)

10.13820/j.cnki.gdyx.20252076

评论